Sakai Chemical Industry Co., Ltd.

Equities

4078

JP3312800000

Commodity Chemicals

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
2,009 JPY -0.74% Intraday chart for Sakai Chemical Industry Co., Ltd. +0.05% +7.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Develops Environmental Friendly Catalyst MT
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 01, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024 CI
Sakai Chemical Industry Co., Ltd. announced that it has received ¥3.03513722 billion in funding from IA Partners Inc. CI
Sakai Chemical Industry Co., Ltd. announced that it expects to receive ¥3.03513722 billion in funding from IA Partners Inc. CI
Sakai Chemical Industry Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Expects to Pay Dividend for the Year Ending March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Sakai Chemical Industry Co., Ltd. Announces Dividend for the End of Second Quarter Ended September 30, 2022, Payable on December 1, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023 CI
Sakai Chemical Industry Installs Solar Generation System at Onahama Manufacturing Site’s Otsurugi Plant MT
Sakai Chemical Industry Co., Ltd. Announces Introduction of Solar Power Generation Facilities CI
Sakai Chemical's FighZinc Series Passes Safety Standards MT
Sakai Chemical Industry Co., Ltd. Provides Financial Guidance for the Six Months Ending September 30, 2022 and Full Year 2023 CI
Sakai Chemical Recovers from Loss in FY22 over Lack of Impairment Losses MT
Sakai Chemical Industry Co., Ltd. Provides Dividend Guidance for the Second Quarter 2022 and Full Year Ending March 31, 2023; Announces Dividend for the Year Ended March 31, 2022 CI
Sakai Chemical Industry Co., Ltd. Provides Financial Guidance for the Six Months Ending September 30, 2022 and Full Year Ending March 31, 2023 CI
Tranche Update on Sakai Chemical Industry Co., Ltd.'s Equity Buyback Plan announced on October 12, 2021. CI
Sakai Chemical Industry Co., Ltd.'s Equity Buyback announced on October 12, 2021, has expired with 682,300 shares, representing 4.05% for ¥1,499.91 million. CI
Chart Sakai Chemical Industry Co., Ltd.
More charts
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2,009 JPY
Average target price
2,500 JPY
Spread / Average Target
+24.44%
Consensus
  1. Stock Market
  2. Equities
  3. 4078 Stock
  4. News Sakai Chemical Industry Co., Ltd.
  5. Sakai Chemical Industry Installs Solar Generation System at Onahama Manufacturing Site’s Otsurugi Plant